Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CHD Risk-Equivalent Disease”

7 trials

Showing 7 of 7 results

Testing effectiveness (Phase 2)Study completedNCT00353522
What this trial is testing

RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.

Who this might be right for
Coronary Heart Disease
Hoffmann-La Roche 135
Large-scale testing (Phase 3)Study completedNCT01516541
What this trial is testing

Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease

Who this might be right for
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
Hoffmann-La Roche 2,220
Testing effectiveness (Phase 2)Study completedNCT00269048
What this trial is testing

SB-480848 In Subjects With Coronary Heart Disease

Who this might be right for
Atherosclerosis
GlaxoSmithKline 969
Large-scale testing (Phase 3)Study completedNCT00551447
What this trial is testing

A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)

Who this might be right for
Coronary Disease
Organon and Co 616
Testing effectiveness (Phase 2)Study completedNCT00655538
What this trial is testing

A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients

Who this might be right for
Coronary Heart Disease
Hoffmann-La Roche 476
Large-scale testing (Phase 3)Study completedNCT00653588
What this trial is testing

Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 Weeks

Who this might be right for
HypercholesterolemiaCoronary Heart Disease
AstraZeneca
Large-scale testing (Phase 3)Study completedNCT00685776
What this trial is testing

Study to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019)

Who this might be right for
Coronary Heart Disease (CHD)CHD Risk-Equivalent Disease
Merck Sharp & Dohme LLC 1,623

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation